Literature DB >> 20652158

Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.

Richard N Fedorak1, Sander Veldhuyzen van Zanten, Ron Bridges.   

Abstract

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada. The current article presents the updated findings from the study concerning gastroesophageal reflux disease - a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications (Montreal definition).

Entities:  

Mesh：

Year:  2010        PMID： 20652158      PMCID： PMC2918483          DOI： 10.1155/2010/296584

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  20 in total

1.  Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.

Authors:  F Bursey; M Crowley; C Janes; C J Turner
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

3.  Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population.

Authors:  J Kotzan; W Wade; H H Yu
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

4.  Epidemiology of oesophageal reflux disease.

Authors:  R C Heading
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 5.  Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.

Authors:  David Armstrong; John K Marshall; Naoki Chiba; Robert Enns; Carlo A Fallone; Ronnie Fass; Roger Hollingworth; Richard H Hunt; Peter J Kahrilas; Serge Mayrand; Paul Moayyedi; William G Paterson; Dan Sadowski; Sander Jo Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2005-01       Impact factor: 3.522

Review 6.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Authors:  Nicholas Shaheen; David F Ransohoff
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

Review 7.  Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children.

Authors:  Eric Hassall
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

8.  Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis.

Authors:  K Blondeau; A Pauwels; Lj Dupont; V Mertens; M Proesmans; R Orel; J Brecelj; M López-Alonso; Mj Moya; A Malfroot; E De Wachter; Y Vandenplas; B Hauser; D Sifrim
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

Review 9.  Review article: epidemiology and management of gastro-oesophageal reflux in children.

Authors:  B D Gold
Journal:  Aliment Pharmacol Ther       Date:  2004-02       Impact factor: 8.171

Review 10.  The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.

Authors:  K D Bardhan
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171
View more
  12 in total

Review 1.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

2. 

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

3.  Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China.

Authors:  Zhuolin Zhang; Yuwen Bao; Lele Cai; Yajie Gu; Ting Yang; Xin Li
Journal:  Clin Drug Investig       Date:  2022-08-22       Impact factor: 3.580

4.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

5.  Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication.

Authors:  Awais Ashfaq; Hyun K Daniel Rhee; Kristi L Harold
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.

Authors:  Valentin Becker; Stefan Grotz; Christoph Schlag; Simon Nennstiel; Analena Beitz; Bernhard Haller; Roland M Schmid; Alexander Meining; Monther Bajbouj
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence.

Authors:  Shahin Ayazi; Nobel Chowdhury; Ali H Zaidi; Kristy Chovanec; Yoshihiro Komatsu; Ashten N Omstead; Ping Zheng; Toshitaka Hoppo; Blair A Jobe
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

8.  Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.

Authors:  Merel M Tielemans; Martijn G H van Oijen
Journal:  BMC Gastroenterol       Date:  2013-10-01       Impact factor: 3.067

9.  The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-13

10.  Are Anxious and Depressive Symptoms Associated with Gastrointestinal Symptoms in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)?

Authors:  Marisa J Perera; Neil Schneiderman; Daniela Sotres-Alvarez; Martha Daviglus; Silvia M Mirabal; Maria M Llabre
Journal:  J Racial Ethn Health Disparities       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.